Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

Determining IPO prices for innovative firms: the case of young French bio-medtech firms

Abstract : The large number of French biotech firms that have recently gone public prompts us to analyse the role and characteristics of their initial backers and their influence in determining the offer price at the time of the IPO. We assume the offer price is set so as to underprice companies in conjunction with the exit motives of their main shareholders and the nature and characteristics of the venture capital firms backing them. The paper characterizes listed bio-medtech firms, although the results sometimes fail to reveal underpricing for the 39 bio-medtech firms that went public on Euronext Paris between 2010 and 2016.
Keywords : Prices Bio-medtech
Type de document :
Article dans une revue
Liste complète des métadonnées

https://hal-univ-bourgogne.archives-ouvertes.fr/hal-02959933
Contributeur : Crego - Université de Bourgogne <>
Soumis le : mercredi 7 octobre 2020 - 11:33:42
Dernière modification le : jeudi 8 octobre 2020 - 03:34:00

Identifiants

  • HAL Id : hal-02959933, version 1

Citation

Evelyne Poincelot, Dominique Poincelot. Determining IPO prices for innovative firms: the case of young French bio-medtech firms. Bankers, Markets and Investors, 2019, 159 (1), pp.1-16. ⟨hal-02959933⟩

Partager

Métriques

Consultations de la notice

8